Structure-Activity Relationships of Sesquiterpene Lactones

ABSTRACT: Sesquiterpene lactones (STLs) are one of the largest biogenetically homogenous groups of natural products known. Currently, the Dictionary of Natural Products holds a total of over 11000 entries on sesquiterpenes, of which almost 5000 contain at least one lactone group. One reason for the large number of individual compounds and the associated structural diversity of this class of natural products is most certainly related to their enormously broad spectrum of biological activities, rendering them a highly valuable defense tool for those organisms synthesizing them. It is thus no surprise that the plant family from which most STLs have been isolated, i.e. the Compositae, is among the largest and ecologically most diverse plant families on our planet. Many of the biological activities of the most common types of STLs are known to be mediated by a simple general chemical mechanism, i.e. alkylation of biological macromolecules in terms of Michael type additions. These effects have been surveyed in numerous comprehensive reviews. Moreover, some very specific receptor-mediated activities of less frequent types of STLs are known. Quite surprisingly, despite the plethora of reports on STL bioactivity, only very few systematic studies on structure-activity relationships have been carried out. Detailed studies of this kind, however, would be highly desirable with respect to several aspects of medicinal/pharmaceutical, agrochemical and ecological interest. Most importantly, many STL-containing plants have been used in traditional medicines of all cultures for many centuries and continue to be utilized also in modern phytotherapy. Therapeutic use of STLs as pure chemicals is - in spite of their broad utilization in form of plants or crude extracts-restricted to very few examples, which is mainly due to a lack of knowledge on the structural requirements for selectivity with respect to a desired biological activity. It may, however, be conceived, that STLs could play a valuable role as lead structures to new therapeutic agents, if more information, especially in the form of quantitative structure-activity relationships (QSAR), existed. The present chapter attempts to present an overview on the current knowledge on structure-activity relationships of STLs of different types and different activities. Selected examples of current research in the author’s laboratory on structure-reactivity- and structure-activity relationships of STLs are presented.

[1]  K. Schaumburg,et al.  Stereochemistry and carbon-13 nuclear magnetic resonance of the histamineliberating sesquiterpene lactone thapsigargin. A modification of Horeau's method , 1983 .

[2]  M. Schmitz,et al.  Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF‐κB , 1997, FEBS letters.

[3]  Carlos R Rodrigues,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies. , 2002, Journal of medicinal chemistry.

[4]  R García-Domenech,et al.  Discovery of New Antimalarial Compounds by use of Molecular Connectivity Techniques , 1999, The Journal of pharmacy and pharmacology.

[5]  Jing Wen,et al.  Oxidative Stress-mediated Apoptosis , 2002, The Journal of Biological Chemistry.

[6]  M. Akamatsu,et al.  Non-competitive GABA antagonists: probing the mechanisms of their selectivity for insect versus mammalian receptors. , 2001, Pest management science.

[7]  Abhishek Gupta,et al.  Phytochemistry of Medicinal Plants , 1995, Recent Advances in Phytochemistry.

[8]  F. Fronczek,et al.  The molecular structure of 2alpha-hydroxyneoanisatin and structure-activity relationships among convulsant sesquiterpenes of the seco-prezizaane and picrotoxane types. , 1999, Bioorganic & medicinal chemistry.

[9]  Ralph G. Pearson,et al.  HARD AND SOFT ACIDS AND BASES , 1963 .

[10]  M. Nakasako,et al.  Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 Å resolution , 2000, Nature.

[11]  R. ffrench-Constant,et al.  A unique amino acid of the Drosophila GABA receptor with influence on drug sensitivity by two mechanisms. , 1994, The Journal of physiology.

[12]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[13]  Youko Tamura,et al.  Re-investigation of the conformation of laurenobiolide, A ten-membered ring sesquiterpene lactone by variable-temperature carbon-13 NMR spectroscopy. Evidence for the presence of four conformational isomers in solution , 1976 .

[14]  Jarboe Ch,et al.  Structural aspects of picrotoxinin action. , 1968 .

[15]  H. Pahl,et al.  Endoplasmicreticulum-induced signal transduction and gene expression. , 1997, Trends in cell biology.

[16]  Y. Kudo,et al.  Anisatin, a potent GABA antagonist, isolated from Illicium anisatum , 1981, Neuroscience Letters.

[17]  M. Heinrich,et al.  Natural products as targeted modulators of the nuclear factor‐KB pathway , 2002, The Journal of pharmacy and pharmacology.

[18]  S. Laufer,et al.  Studies on the Anti-Inflammatory Activity of Phytopharmaceuticals Prepared from Arnica Flowers1 , 2002, Planta medica.

[19]  J. Heilmann,et al.  Quantitative Structure-Cytotoxicity Relationships of Sesquiterpene Lactones derived from partial charge (Q)-based fractional Accessible Surface Area Descriptors (Q_frASAs) , 2002 .

[20]  M. Boyd,et al.  Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen , 1995 .

[21]  T. Schmidt Helenanolide type sesquiterpene lactones Part 1. Conformations and molecular dynamics of helenalin, its esters and 11,13-dihydro derivatives , 1996 .

[22]  Heinz Mehlhorn,et al.  Encyclopedic reference of parasitology , 2001 .

[23]  Prashant V Desai,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 8. design, synthesis, and CoMFA studies toward the development of artemisinin-based drugs against leishmaniasis and malaria. , 2003, Journal of medicinal chemistry.

[24]  Y. Sagara,et al.  Characterization of the inhibition of intracellular Ca2+ transport ATPases by thapsigargin. , 1992, The Journal of biological chemistry.

[25]  S. Christensen,et al.  Structure of histamine releasing guaianolides from Thapsia species , 1984 .

[26]  J. Wade,et al.  A conformational mechanism for formation of a dead-end complex by the sarcoplasmic reticulum ATPase with thapsigargin. , 1992, The Journal of biological chemistry.

[27]  Klaus Raming,et al.  Cloning and functional expression of GABAB receptors from Drosophila , 2001 .

[28]  F. Fronczek,et al.  Revision of the Structure of Dunnianin and Related Sesquiterpene Lactones from Illicium Species , 1997 .

[29]  M. Satake,et al.  New sesquiterpene lactones from Elephantopus mollis and their leishmanicidal activities. , 2001, Planta medica.

[30]  Y. Sagara,et al.  Thapsigargin, a high affinity and global inhibitor of intracellular Ca2+ transport ATPases. , 1992, Archives of biochemistry and biophysics.

[31]  Abby L. Parrill,et al.  Rational drug design : novel methodology and practical applications , 1999 .

[32]  Márcia M. C. Ferreira,et al.  Artemisinin Derivatives with Antimalarial Activity against Plasmodium falciparum Designed with the Aid of Quantum Chemical and Partial Least Squares Methods , 2003 .

[33]  D. L. Klayman,et al.  Qinghaosu (artemisinin): an antimalarial drug from China , 1985 .

[34]  Schmidt Novel seco-prezizaane sesquiterpenes from north american illicium species , 1999, Journal of natural products.

[35]  A. K. Picman Biological activities of sesquiterpene lactones , 1986 .

[36]  J. Mitchell,et al.  Reaction of alantolactone, an allergenic sesquiterpene lactone, with some amino acids. Resultant loss of immunologic reactivity. , 1974, Canadian journal of biochemistry.

[37]  K. Koike,et al.  Picrodendrin and related terpenoid antagonists reveal structural differences between ionotropic GABA receptors of mammals and insects. , 1998, Bioorganic & medicinal chemistry.

[38]  S. Albuquerque,et al.  A study of the trypanocidal and analgesic properties from Lychnophora granmongolense (Duarte) Semir & Leitão Filho , 2000, Phytotherapy research : PTR.

[39]  S. Christensen,et al.  Thapsigargin analogues for targeting programmed death of androgen-independent prostate cancer cells. , 1999, Bioorganic & medicinal chemistry.

[40]  W. Campbell Ivermectin as an antiparasitic agent for use in humans. , 1991, Annual review of microbiology.

[41]  S. M. Kupchan,et al.  Reactions of Alpha Methylene Lactone Tumor Inhibitors with Model Biological Nucleophiles , 1970, Science.

[42]  H. Pahl,et al.  Activation of transcription factor NF-kappaB by the adenovirus E3/19K protein requires its ER retention , 1996, The Journal of cell biology.

[43]  David J. Livingstone,et al.  Data Analysis for Chemists: Applications to QSAR and Chemical Product Design , 1996 .

[44]  I. Krull,et al.  Reversible thiol addition as a protecting reaction for conjugated α-methylene groups of lactones , 1970 .

[45]  S. Christensen,et al.  The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response , 1985, British journal of pharmacology.

[46]  Fischer,et al.  New Sesquiterpene Lactones from Illicium floridanum , 1998, Journal of natural products.

[47]  J. Phillipson,et al.  Antiprotozoal Agents from Plant Sources , 1991, Planta medica.

[48]  S. Christensen,et al.  Phytochemistry of the genus Thapsia. , 1981, Planta medica.

[49]  B. Mannervik,et al.  Glutathione transferases--structure and catalytic activity. , 1988, CRC critical reviews in biochemistry.

[50]  B M Hausen,et al.  Structure‐activity aspects of 4 allergenic sesquiterpene lactones tacking the exocyclic α‐methylene at the lactone ring , 1985, Contact dermatitis.

[51]  V. Sylvia,et al.  The sesquiterpene lactone hymenoxon acts as a bifunctional alkylating agent , 1987, Cell Biology and Toxicology.

[52]  H. Pahl,et al.  Cysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones* , 2001, The Journal of Biological Chemistry.

[53]  T. Ibuka,et al.  Structure-antimicrobial activity relationships among the sesquiterpene lactones and related compounds , 1977 .

[54]  J. Casida,et al.  [35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites. , 1983, Molecular pharmacology.

[55]  T. G. Waddell,et al.  Mode of action of sesquiterpene lactones as anti-inflammatory agents. , 1980, Journal of pharmaceutical sciences.

[56]  Han van de Waterbeemd,et al.  Drug bioavailability : estimation of solubility, permeability, absorption and bioavailability , 2003 .

[57]  S. Chaney,et al.  Inhibition of inosine monophosphate dehydrogenase by sesquiterpene lactones. , 1987, Biochimica et biophysica acta.

[58]  Hiromi Nomura,et al.  Structural changes in the calcium pump accompanying the dissociation of calcium , 2002, Nature.

[59]  S. Snyder,et al.  Barbiturate recognition site on the GABA/benzodiazepine receptor complex is distinct from the picrotoxinin/TBPS recognition site. , 1984, European journal of pharmacology.

[60]  C. Newland,et al.  On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. , 1992, The Journal of physiology.

[61]  Y. Fujiyoshi,et al.  Structure and gating mechanism of the acetylcholine receptor pore , 2003, Nature.

[62]  R. Pickersgill,et al.  Structure of monoclinic papain at 1.60 Å resolution , 1992 .

[63]  H. Pahl,et al.  Inhibition of transcription factor NF-kappaB by sesquiterpene lactones: a proposed molecular mechanism of action. , 1999, Bioorganic & medicinal chemistry.

[64]  S. M. Kupchan,et al.  Tumor inhibitors. 69. Structure-cytotoxicity relationships among the sesquiterpene lactones. , 1971, Journal of medicinal chemistry.

[65]  J. Ferrendelli,et al.  Alkyl-substituted γ-butyrolactones act at a distinct site allosterically linked to the TBPS/picrotoxinin site on the GABAA receptor complex , 1993, Brain Research.

[66]  P. Raven,et al.  Biology of Plants. , 1971 .

[67]  S. Christensen,et al.  Absolute configurations of the histamine liberating sesquiterpene lactones thapsigargin and trilobolide , 1985 .

[68]  Anne Robert,et al.  Is alkylation the main mechanism of action of the antimalarial drug artemisinin , 1998 .

[69]  H. J. Woerdenbag,et al.  Cytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC4 and the COLO 320 cell lines. , 1994, Planta medica.

[70]  T. Schmidt,et al.  Helenanolide-type sesquiterpene lactones--III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. , 1997, Bioorganic & medicinal chemistry.

[71]  Kinzo Matsumoto,et al.  Anisatin modulation of GABA- and pentobarbital-induced enhancement of diazepam binding in rat brain , 1982, Neuroscience Letters.

[72]  T. Shapiro,et al.  Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy. , 2003, Journal of medicinal chemistry.

[73]  T. Schmidt Glutathione adducts of helenalin and 11 alpha,13-dihydrohelenalin acetate inhibit glutathione S-transferase from horse liver. , 2000, Planta medica.

[74]  I. Merfort,et al.  The effect of sesquiterpene lactones on the release of human neutrophil elastase. , 2003, Biochemical pharmacology.

[75]  A. Lee,et al.  Mechanism of inhibition of the calcium pump of sarcoplasmic reticulum by thapsigargin. , 1992, The Biochemical journal.

[76]  F. Seaman Sesquiterpene lactones as taxonomic characters in the asteraceae , 1983 .

[77]  S. Christensen,et al.  Design, synthesis, and pharmacological evaluation of thapsigargin analogues for targeting apoptosis to prostatic cancer cells. , 2001, Journal of medicinal chemistry.

[78]  H. J. Woerdenbag,et al.  Cytotoxicity of Artemisinin, a Dimer of Dihydroartemisinin, Artemisitene and Eupatoriopicrin as Evaluated by the MTT and Clonogenic Assay , 1996 .

[79]  R. Gil,et al.  Aromatase inhibition by an 11,13-dihydroderivative of a sesquiterpene lactone. , 2001, The Journal of pharmacology and experimental therapeutics.

[80]  Jean M. J. Tronchet,et al.  Correlating the Molecular Electrostatic Potentials of Some Organic Peroxides with Their Antimalarial Activities , 2000, J. Chem. Inf. Comput. Sci..

[81]  V. Muñoz,et al.  Antiprotozoal activity of dehydrozaluzanin C, a sesquiterpene lactone isolated from Munnozia maronii (asteraceae) , 1993 .

[82]  C. January,et al.  Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805C* , 2003, Journal of Biological Chemistry.

[83]  B. Meunier,et al.  Characterization of the First Covalent Adduct between Artemisinin and a Heme Model , 1997 .

[84]  W. Milhous,et al.  Structure-activity relationships of the antimalarial agent artemisinin. 1. Synthesis and comparative molecular field analysis of C-9 analogs of artemisinin and 10-deoxoartemisinin. , 1993, Journal of medicinal chemistry.

[85]  U. Sankawa,et al.  Biologically active constituents of Centipeda minima: sesquiterpenes of potential anti-allergy activity. , 1991, Chemical & pharmaceutical bulletin.

[86]  N. Akaike,et al.  Blockade of γ-aminobutyric acid-gated chloride current in frog sensory neurons by picrotoxin , 1988, Neuroscience Research.

[87]  H. Pahl,et al.  Helenanolide type sesquiterpene lactones. Part 5: the role of glutathione addition under physiological conditions. , 1999, Bioorganic & medicinal chemistry.

[88]  H. J. Woerdenbag,et al.  Antiplasmodial Activities and Cytotoxic Effects of Aqueous Extracts and Sesquiterpene Lactones from Neurolaena lobata* , 1996, Planta medica.

[89]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[90]  J. H. Park,et al.  Costunolide induces apoptosis by ROS-mediated mitochondrial permeability transition and cytochrome C release. , 2001, Biological & pharmaceutical bulletin.

[91]  R. H. Elliott,et al.  Cardiac-inhibiting properties of the sesquiterpene lactone, parthenin, in the migratory grasshopper, Melanoplus sanguinipes , 1981 .

[92]  S. Christensen,et al.  Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage , 2005, Agents and Actions.

[93]  M. Gurrath,et al.  Structure-activity relationships of seco-prezizaane and picrotoxane/picrodendrane terpenoids by Quasar receptor-surface modeling. , 2004, Bioorganic & medicinal chemistry.

[94]  D. Bredesen,et al.  Bcl‐2 Protects Against Apoptosis in Neuronal Cell Line Caused by Thapsigargin‐Induced Depletion of Intracellular Calcium Stores , 1998, Journal of neurochemistry.

[95]  K. Schulze-Osthoff,et al.  Sesquiterpene Lactones Specifically Inhibit Activation of NF-κB by Preventing the Degradation of IκB-α and IκB-β* , 1998, The Journal of Biological Chemistry.

[96]  V. Sylvia,et al.  Alkylation of deoxyguanosine by the sesquiterpene lactone hymenoxon. , 1985, Toxicology letters.

[97]  D. Knight,et al.  Feverfew: chemistry and biological activity. , 1995, Natural product reports.

[98]  Y. Kaneko,et al.  Thapsigargin, a Ca2+‐ATPase inhibitor, depletes the intracellular Ca2+ pool and induces apoptosis in human hepatoma cells. , 1993 .

[99]  J. Bagli,et al.  A simple synthesis of equilin , 1964 .

[100]  T. G. Waddell,et al.  Sesquiterpene antitumor agents: inhibitors of cellular metabolism. , 1977, Science.

[101]  T. Shapiro,et al.  Antimalarial, antiproliferative, and antitumor activities of artemisinin-derived, chemically robust, trioxane dimers. , 1999, Journal of medicinal chemistry.

[102]  Max Dobler,et al.  5D-QSAR: the key for simulating induced fit? , 2002, Journal of medicinal chemistry.

[103]  S. Meshnick,et al.  Artemisinin: mechanisms of action, resistance and toxicity. , 2002, International journal for parasitology.

[104]  J. Heilmann,et al.  The influence of glutathione and cysteine levels on the cytotoxicity of helenanolide type sesquiterpene lactones against KB cells. , 2001, Bioorganic & medicinal chemistry.

[105]  Alastair M. Hosie,et al.  Actions of picrodendrin antagonists on dieldrin‐sensitive and ‐resistant Drosophila GABA receptors , 1996, British journal of pharmacology.

[106]  T. Schmidt,et al.  Inhibitory effects of helenalin and related compounds on 5-lipoxygenase and leukotriene C(4) synthase in human blood cells. , 2001, Biochemical pharmacology.

[107]  H. J. Woerdenbag,et al.  Stereochemistry-dependent cytotoxicity of some artemisinin derivatives. , 1997, Journal of natural products.

[108]  H. J. Woerdenbag,et al.  Structure-cytotoxicity relationships of some helenanolide-type sesquiterpene lactones. , 1997, Journal of natural products.

[109]  K. Takeda Stereospecific cope rearrangement of the germacrene-type sesquiterpenes , 1974 .

[110]  R. Brun,et al.  Anti-trypanosomal activity of helenalin and some structurally related sesquiterpene lactones. , 2002, Planta medica.

[111]  U. Sankawa,et al.  Biologically active constituents of Centipeda minima: isolation of a new plenolin ester and the antiallergy activity of sesquiterpene lactones. , 1985, Chemical & pharmaceutical bulletin.

[112]  J. Gertsch,et al.  Influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in Jurkat T cells and human peripheral blood cells: anti-inflammatory and cytotoxic effects. , 2003, Biochemical pharmacology.

[113]  K. Malcolm,et al.  Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways. , 1992, The Journal of pharmacology and experimental therapeutics.

[114]  Johann Gasteiger,et al.  Handbook of Chemoinformatics , 2003 .

[115]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[116]  S. Krishna,et al.  Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.

[117]  K. Wakamatsu,et al.  Stereocontrolled total synthesis of (-)-anisatin: a neurotoxic sesquiterpenoid possessing a novel spiro .beta.-lactone , 1990 .

[118]  D. Desmaële,et al.  Structure–Activity Relationships of Synthetic Tricyclic Trioxanes Related to Artemisinin: The Unexpected Alkylative Property of a 3-(Methoxymethyl) Analog , 1999 .

[119]  P. Andrews,et al.  Conformational requirements for convulsant compounds , 1989 .

[120]  Mitchell A. Avery,et al.  Comparison of 3D quantitative structure-activity relationship methods: Analysis of the in vitro antimalarial activity of 154 artemisinin analogues by hypothetical active-site lattice and comparative molecular field analysis , 1998, J. Comput. Aided Mol. Des..

[121]  F. Fronczek,et al.  New allo-cedrane type sesquiterpene hemiketals and further sesquiterpene lactones from fruits of Illicium floridanum. , 2001, Journal of natural products.

[122]  D. Covey,et al.  Multiple mechanisms of picrotoxin block of GABA‐induced currents in rat hippocampal neurons. , 1993, The Journal of physiology.

[123]  F. Opperdoes,et al.  Natural products active against African trypanosomes: a step towards new drugs. , 2004, Natural product reports.

[124]  Y. Sagara,et al.  Inhibition of the sarcoplasmic reticulum Ca2+ transport ATPase by thapsigargin at subnanomolar concentrations. , 1991, The Journal of biological chemistry.

[125]  S. Christensen,et al.  Structure-activity relationships of analogues of thapsigargin modified at O-11 and O-12. , 1995, Journal of medicinal chemistry.

[126]  John Geibel,et al.  Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells , 2002, Nature Medicine.

[127]  Kinzo Matsumoto,et al.  Anisatin modulation of temperature-dependent inhibition of [3H]muscimol binding by chloride ion , 1983, Brain Research.

[128]  A. Vollmar,et al.  Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2. , 2001, Cancer research.

[129]  C. Lipinski Drug-like properties and the causes of poor solubility and poor permeability. , 2000, Journal of pharmacological and toxicological methods.

[130]  H. Pahl,et al.  Helenalin, an Anti-Inflammatory Sesquiterpene Lactone from Arnica, Selectively Inhibits Transcription Factor NF-κB , 1997 .

[131]  J. Poulsen,et al.  Derivatives of thapsigargin as probes of its binding site on endoplasmic reticulum Ca2+ ATPase , 1993, FEBS letters.

[132]  Vudhichai Parasuk,et al.  QSAR study of antimalarial activities and artemisinin-heme binding properties obtained from docking calculations. , 2000 .

[133]  Y. Sagara,et al.  Specific inhibitors of intracellular Ca2+ transport ATPases , 1994, The Journal of Membrane Biology.

[134]  H. Lilja,et al.  Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. , 2003, Journal of the National Cancer Institute.

[135]  T. G. Waddell,et al.  Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones. , 1977, Journal of medicinal chemistry.

[136]  B. Magnusson,et al.  Patch test sensitization to D & C Yellow No. 11 and simultaneous reaction to Quinoline Yellow , 1981, Contact dermatitis.

[137]  Ramon Carbó-Dorca,et al.  Modeling Antimalarial Activity: Application of Kinetic Energy Density Quantum Similarity Measures as Descriptors in QSAR , 2000, J. Chem. Inf. Comput. Sci..

[138]  G. François,et al.  Pseudoguaianolide sesquiterpene lactones with high activities against the human malaria parasite Plasmodium falciparum , 2004, Phytotherapy research : PTR.

[139]  H. J. Woerdenbag,et al.  Artemisinin-Derived Sesquiterpene Lactones as Potential Antitumour Compounds: Cytotoxic Action against Bone Marrow and Tumour Cells , 1998, Planta medica.

[140]  J. Liu STRUCTURE AND REACTION OF ARTEANNUIN , 1979 .

[141]  T. Fujita,et al.  Sites of Action of Noncompetitive GABA Antagonists in Houseflies and Rats: Three-Dimensional QSAR Analysis , 1997 .

[142]  H. Pahl,et al.  The Anti-inflammatory Sesquiterpene Lactone Helenalin Inhibits the Transcription Factor NF-κB by Directly Targeting p65* , 1998, The Journal of Biological Chemistry.

[143]  F. Fronczek,et al.  Helenanolide-type sesquiterpene lactones. Part 2. The molecular conformations of arnifolin and some related helenanolides as determined by X-ray crystallographic and NMR spectroscopic analyses , 1996 .

[144]  Alastair M. Hosie,et al.  Molecular biology of insect neuronal GABA receptors , 1997, Trends in Neurosciences.

[145]  B L Kalman,et al.  Computer-assisted modeling of the picrotoxinin and gamma-butyrolactone receptor site. , 1983, Molecular pharmacology.

[146]  E. Okuyama,et al.  Structure-activity relationships of seco-prezizaane terpenoids in gamma-aminobutyric acid receptors of houseflies and rats. , 2002, Bioorganic & medicinal chemistry.

[147]  S. Christensen,et al.  Toxicodynamics of tumour promoters of mouse skin III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay , 2005, Journal of Cancer Research and Clinical Oncology.